Filing Details
- Accession Number:
- 0001499807-17-000096
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-08-15 17:25:21
- Reporting Period:
- 2017-08-11
- Filing Date:
- 2017-08-15
- Accepted Time:
- 2017-08-15 17:25:21
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1499807 | K2M Group Holdings Inc. | KTWO | Surgical & Medical Instruments & Apparatus (3841) | 272977810 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1605499 | S Gregory Cole | C/O K2M Group Holdings, Inc. 600 Hope Parkway Se Leesburg VA 20175 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2017-08-11 | 39,357 | $9.26 | 96,865 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2017-08-11 | 39,357 | $23.37 | 57,508 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2017-08-11 | 39,357 | $0.00 | 39,357 | $9.26 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2017-02-01 | 2021-02-26 | No | 4 | M | Direct |
Footnotes
- Reflects the number of shares beneficially owned after taking into account a correction to the number of shares purchased under the issuer's stock purchase plan reflected in the Form 4 filed on July 5, 2017.
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
- The price in Column 4 is a weighted average. The prices actually received ranged from $23.20 to $23.62. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
Billionaire Hedge Funds
